{
    "organizations": [],
    "uuid": "2fce3ea726001c19da3d65d860bb8a87d99d243d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangzhou-wondfo-biotech-sees-2017/brief-guangzhou-wondfo-biotech-sees-2017-net-profit-up-30-pct-to-55-pct-idUSL3N1PC1GY",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangzhou Wondfo Biotech sees 2017 net profit up 30 pct to 55 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17(Reuters) - Guangzhou Wondfo Biotech Co Ltd\n* Sees 2017 net profit to be increase by 30 percent to 55 percent, or to be 188.5 million yuan to 224.7 million yuan\n* Says 2016 net profit was 145 million yuan\n* Says that increased operation revenue, enhancement of profitability, and increased management expenses and sales expenses as main reasons for the forecast\nSource text in Chinese: goo.gl/gaRV1r\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-17T10:36:00.000+02:00",
    "crawled": "2018-01-17T19:47:03.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "guangzhou",
        "wondfo",
        "biotech",
        "co",
        "ltd",
        "see",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "net",
        "profit",
        "million",
        "yuan",
        "say",
        "increased",
        "operation",
        "revenue",
        "enhancement",
        "profitability",
        "increased",
        "management",
        "expense",
        "sale",
        "expense",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}